Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Cancer Medicine|September 4, 2020
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphomaBeatrice Casadei, Lisa Argnani, Alice Morigi, et al.
Annals of Hematology|May 2, 2024
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activityRossana Di Staso, Beatrice Casadei, Marianna Gentilini, et al.
Hematological Oncology|September 9, 2020
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experienceBeatrice Casadei, Lisa Argnani, Alice Morigi, et al.
Leukemia & Lymphoma|March 2, 2019
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patientsAlessandro Broccoli, Sergio Nicola Forti Parri, Cinzia Pellegrini, et al.
Hematological Oncology|October 15, 2021
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemiaAlessandro Broccoli, Carolina Terragna, Laura Nanni, et al.
Journal of Robotic Surgery|June 22, 2025
Medical students' attitude toward robotic surgery: time to revise medical school curricula?Antonio Gangemi, Paolo M Russo, Lisa Argnani, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2020
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphomaAlessandro Broccoli, Cristina Nanni, Alberta Cappelli, et al.
Cancer Medicine|March 19, 2016
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 yearsBeatrice Casadei, Cinzia Pellegrini, Alessandro Pulsoni, et al.
Tumori|April 20, 2022
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case seriesAlessandro Broccoli, Lisa Argnani, Paolo Elia Coppola, et al.
Hematological Oncology|June 29, 2020
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patientsAlice Morigi, Lisa Argnani, Ginevra Lolli, et al.
Pageof 10